Home
>
ipos-financial-filings
| Revenue | $5,849,633.00 |
|---|---|
| Net Income | $3,596,644.00 |
| Total Assets | $18,943,105.00 |
| Total Liabilities | $$527,753.00 |
| Stockholders' Equity | $18,415,352.00 |
| COMPANY NAME | FORM TYPE | DATE RECEIVED | VIEW |
|---|---|---|---|
| Anbio Biotechnology | F-1 | 2024-12-31 00:00:00 | Link |
| Anbio Biotechnology | F-1/A | 2025-01-10 00:00:00 | Link |
| Anbio Biotechnology | F-1/A | 2025-01-24 00:00:00 | Link |
| Anbio Biotechnology | F-1/A | 2025-02-10 00:00:00 | Link |
| Anbio Biotechnology | F-1 | 2024-12-31 00:00:00 | Link |
| Anbio Biotechnology | F-1/A | 2025-01-10 00:00:00 | Link |
| Anbio Biotechnology | F-1/A | 2025-01-24 00:00:00 | Link |
| Anbio Biotechnology | F-1/A | 2025-02-10 00:00:00 | Link |
| Anbio Biotechnology | 424B4 | 2025-02-19 00:00:00 | Link |
